Found: 5
Select item for more details and to access through your institution.
The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204668
- By:
- Publication type:
- Article
The usefulness of determining the presence of BRAF V600E mutation in fine-needle aspiration cytology in indeterminate cytological results.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2016, v. 67, n. 1, p. 41, doi. 10.5603/EP.2016.0006
- By:
- Publication type:
- Article
Response to therapy of papillary thyroid cancer of known BRAF status.
- Published in:
- Clinical Endocrinology, 2017, v. 87, n. 6, p. 815, doi. 10.1111/cen.13423
- By:
- Publication type:
- Article
CHEK 2 mutations and the risk of papillary thyroid cancer.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 3, p. 548, doi. 10.1002/ijc.29426
- By:
- Publication type:
- Article
The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153242
- By:
- Publication type:
- Article